首页|期刊导航|山西医科大学学报|基于单细胞测序的骨肉瘤异质性解析及预后风险预测模型的构建

基于单细胞测序的骨肉瘤异质性解析及预后风险预测模型的构建OA

Heterogeneity analysis of osteosarcoma based on single-cell sequencing and construction of a prognostic prediction model

中文摘要英文摘要

目的 基于骨肉瘤单细胞测序数据集鉴定不同细胞亚群并分析其功能,筛选各细胞群中核心基因构建风险评估模型.方法 基于GEO数据库中骨肉瘤单细胞测序数据集GSE152048,根据已知细胞标志物基因的表达对各细胞簇进行注释,识别其中肿瘤细胞进行亚群分析,采用GO和KEGG分析各亚群的主要细胞功能,鉴定不同亚群间表达差异最显著的100个基因,进一步分析基因功能并构建预后风险预测模型.结果 基于GEO骨肉瘤单细胞测序数据集,共筛选得到9组肿瘤细胞亚群,各亚群在细胞增殖、有丝分裂、免疫及代谢调控等方面发挥不同功能.进一步根据各亚群中表达差异最大的100个基因,构建了由S100A11,CFH,RPL37A以及HIST1H4C四基因组成的模型,基于该模型可以将骨肉瘤病例分为高风险组和低风险组,其中,高风险组患者的总生存期显著短于低风险组,且患者肿瘤增殖能力显著强于低风险组(P<0.001).结论 本研究在单细胞水平上系统描绘了骨肉瘤细胞的异质性,根据不同细胞间基因表达差异,构建了一组预后风险评估模型,为骨肉瘤的精准分型、预后评估及潜在治疗靶点的开发提供了新的理论依据.

Objective To identify distinct cellular clusters and analyze their functional characteristics based on osteosarcoma single-cell RNA sequencing(scRNA-seq)data,and construct a risk assessment model based on the core genes derived from these subpopulations.Methods Osteosarcoma scRNA-seq data GSE152048 from GEO database were firstly applied to annotate the cell types based on the expression of known marker genes,and the tumor cells were focused for subpopulation analysis.Afterwards,the primary biological functions of each subpopulation were investigated using Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses.Then,the top 100 most significantly differentially expressed genes(DEGs)across subpopulations were identified and analyzed to develop a prognostic risk prediction model.Results Based on GEO osteoarcoma scRNA-seq data,a total of nine tumor cell subpopulations were identified,and different subpopulations exerted distinct functions in cell proliferation,mitosis,immune regulation,and metabolic regulation.Moreover,a four-gene prognostic signature model was successfully constructed based on the most significant DEGs among these subpopulations.Based on the model,osteosarcoma patients were divided into high-risk group and low-risk group,and the survival of patients was significantly lower in high-risk group than in low risk group,and the proliferation ability of tumor was stronger in high-risk group(P<0.001).Conclusion The study systematically delineates the heterogeneity of osteo-sarcoma at single-cell level,and establishes a prognostic risk assessment model based on intercellular gene expression differences,which provides new insights for precise subtyping,prognostic evaluation and identification of potential therapeutic targets in osteosarcoma.

吴亦菲;苗蕾;吴礼泽;薛华英;杨志清;申宁宁;高丽芳;马文霞;王晨

山西医科大学基础医学院,太原 030001山西医科大学基础医学院,太原 030001山西医科大学第二临床医学院病理科山西医科大学第二临床医学院病理科山西医科大学第二医院病理科山西医科大学第二医院病理科山西医科大学第二医院病理科山西医科大学第二医院病理科山西医科大学第二医院病理科

医药卫生

骨肉瘤异质性单细胞测序基因特征风险评估

osteosarcomaheterogeneitysingle-cell sequencinggene signaturerisk assessment

《山西医科大学学报》 2026 (8)

857-866,10

国家自然科学基金项目(82572996)山西省科技厅应用基础研究项目(202303021222333,202403021211135,202403021222467)

10.13753/j.issn.1007-6611.2026.08.002

评论